Dr. Oehler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-667-1340- Is this information wrong?
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2000 - 2003- University of WashingtonResidency, Internal Medicine, 1997 - 2000
Case Western Reserve University School of MedicineClass of 1997
Certifications & Licensure
WA State Medical License 1999 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Actuate 1901: 9-ING-41 in Myelofibrosis Start of enrollment: 2020 Aug 20
- Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL Start of enrollment: 2020 Jan 09
- A Study of TAS1440 With ATRA in Subjects With r/r AML Start of enrollment: 2020 Mar 15
Publications & Presentations
PubMed
- CML and the WHO: Why?Ellin Berman, Neil P Shah, Michael Deninger, Jessica K Altman, Maria Amaya, Kebede Begna, Ravi Bhatia, Onyee Chan, Robert Collins, Peter Curtin, Daniel J DeAngelo, Mic...> ;Journal of Clinical Oncology. 2024 Mar 20
- Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Neil P Shah, Ravi Bhatia, Jessica K Altman, Maria Amaya, Kebede H Begna, Ellin Berman, Onyee Chan, Joan Clements, Robert H Collins, Peter T Curtin, Daniel J DeAngelo, ...> ;Journal of the National Comprehensive Cancer Network. 2024 Feb 1
- Project Confirm: Accelerated Drug Approvals for CML-Response.Norsworthy, K. J., Norsworthy, K. J., Norsworthy, K. J., Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Ch...> ;Clinical Cancer Research. 2024 Jan 5
- Join now to see all
Journal Articles
- Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, Mitoxantrone, and G-CSF with Dose-Escalated Mitoxantrone for relapsed/refractory Acute Myeloid Leukemia or Other H...Kelda M Gardner, Vivian G Oehler, Heather A Smith, Anna B Halpern, Paul C Hendrie, Sarah A Buckley, Roland B Walter, Pamela S Becker, Ryan D Cassaday, Asma Anwar, Bart..., Haematologica
Abstracts/Posters
- Mini- Vs. Regular-Dose CLAG-M (Cladribine, Cytarabine, G-CSF, and Mitoxantrone) in Medically Less Fit Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and Othe...Vivian G. Oehler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Multi-Omic Precision Medicine Clinical Trial in Acute LeukemiaVivian G. Oehler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myel...Vivian G. Oehler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lympho...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Dr. Glenda Gray Among Time Magazine’s ‘100 Most Influential’April 20th, 2017
Grant Support
- Integrating Diagnostics With Therapeutic Strategies In Chronic Myeloid LeukemiaNational Cancer Institute2009–2011
- Examination Of Imatinib Mesylate Resistance In CMLNational Cancer Institute2004–2008
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
Fred Hutchinson Cancer CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
